We are live on ! Find out more
LS

Livforsakringsbolaget Skandia Portfolio holdings

AUM $2.58B
1-Year Est. Return 30.64%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
+30.64%
3 Year Est. Return
+115.62%
5 Year Est. Return
+153.42%
10 Year Est. Return
+554.99%
AUM
$145M
AUM Growth
+$5.78M
Cap. Flow
-$1.43M
Cap. Flow %
-0.99%
Top 10 Hldgs %
23.91%
Holding
187
New
12
Increased
18
Reduced
17
Closed
19

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$1.22M
2
UTHR icon
United Therapeutics
UTHR
+$760K
3
F icon
Ford
F
+$723K
4
HUM icon
Humana
HUM
+$679K
5
CB icon
Chubb
CB
+$539K

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.14M
2
BKI
BUCKEYE TECHNOLOGY INC
BKI
+$815K
3
CYH icon
Community Health Systems
CYH
+$741K
4
SFD
SMITHFIELD FOODS,INC
SFD
+$684K
5
CNO icon
CNO Financial Group
CNO
+$668K

Sector Composition

Rank Sector Weight
1 Healthcare 18.66%
2 Technology 17.87%
3 Financials 16.07%
4 Energy 13.85%
5 Consumer Staples 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
1
Pfizer
PFE
$150B
$5.75M 3.98%
211,046
-42,018
-17% -$1.14M
IBM icon
2
IBM
IBM
$222B
$4.11M 2.85%
23,237
– –
CVX icon
3
Chevron
CVX
$386B
$3.78M 2.61%
31,100
-1,900
-6% -$234K
WMT icon
4
Walmart Inc
WMT
$923B
$3.5M 2.42%
142,113
+7,800
+6% +$197K
CI icon
5
Cigna
CI
$73.3B
$3.26M 2.26%
42,430
-2,700
-6% -$211K
JNJ icon
6
Johnson & Johnson
JNJ
$629B
$3.22M 2.23%
37,129
– –
MSFT icon
7
Microsoft
MSFT
$3.66T
$3.07M 2.13%
92,300
– –
CL icon
8
Colgate-Palmolive
CL
$73.6B
$2.71M 1.88%
45,734
– –
JPM icon
9
JPMorgan Chase
JPM
$971B
$2.57M 1.78%
49,800
– –
CSCO icon
10
Cisco
CSCO
$488B
$2.57M 1.78%
109,656
+18,500
+20% +$459K
XOM icon
11
ExxonMobil
XOM
$657B
$2.5M 1.73%
29,050
+13,500
+87% +$1.22M
COP icon
12
ConocoPhillips
COP
$153B
$2.46M 1.7%
35,339
-2,800
-7% -$187K
MRK icon
13
Merck
MRK
$328B
$2.41M 1.66%
52,967
– –
VLO icon
14
Valero Energy
VLO
$95.1B
$2.31M 1.6%
67,747
– –
AET
15
DELISTED
Aetna Inc
AET
$2.3M 1.59%
35,910
– –
PG icon
16
Procter & Gamble
PG
$335B
$2.16M 1.5%
28,583
– –
MRO
17
DELISTED
Marathon Oil Corporation
MRO
$2.02M 1.4%
57,867
-3,100
-5% -$110K
T icon
18
AT&T
T
$166B
$1.99M 1.38%
77,851
– –
MMM icon
19
3M
MMM
$94.8B
$1.6M 1.11%
16,026
– –
INTC icon
20
Intel
INTC
$509B
$1.52M 1.05%
66,200
– –
ALK icon
21
Alaska Air
ALK
$5.29B
$1.51M 1.05%
48,400
– –
KO icon
22
Coca-Cola
KO
$373B
$1.44M 1%
37,993
– –
GME icon
23
GameStop
GME
$8.32B
$1.43M 0.99%
115,200
-35,600
-24% -$426K
CNO icon
24
CNO Financial Group
CNO
$5.02B
$1.4M 0.97%
96,900
-46,900
-33% -$668K
SNX icon
25
TD Synnex
SNX
$20.4B
$1.39M 0.96%
45,076
– –
1
2 3 4 5

Similar funds

GFA
Gallagher Fiduciary Advisors Rolling Meadows, Illinois $2.58B AUM 8.97% 1-Year Est. Return
AAS
Ameritas Advisory Services Lincoln, Nebraska $2.58B AUM 18.84% 1-Year Est. Return
DCM
Dorsal Capital Management Redwood City, California $2.57B AUM 3.13% 1-Year Est. Return
PCM
Palestra Capital Management New York $2.57B AUM 29.93% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.56B AUM 19.48% 1-Year Est. Return
GAG
GM Advisory Group Melville, New York $2.6B AUM 18.86% 1-Year Est. Return
ECP
Electron Capital Partners New York $2.55B AUM 87.77% 1-Year Est. Return
RCMF
RK Capital Management (Florida) Weston, Florida $2.6B AUM 83.27% 1-Year Est. Return

Livforsakringsbolaget Skandia's Q3 2013 Portfolio in Review

As of Q3 2013, Livforsakringsbolaget Skandia held 187 positions worth $145M, up 4.2% from $139M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Livforsakringsbolaget Skandia's Q3 2013 filing shows 12 new, 18 increased, 17 reduced and 19 closed positions. Its largest new stake was United Therapeutics: 10,403 shares worth $820K. The largest sale was Pfizer, an estimated $1.14M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • Livforsakringsbolaget Skandia's largest Q3 2013 buy was United Therapeutics: 10,403 shares worth $820K.
  • Livforsakringsbolaget Skandia added most to ExxonMobil in Q3 2013, an estimated $1.22M increase.
  • Livforsakringsbolaget Skandia's biggest Q3 2013 reduction was Pfizer, cutting an estimated $1.14M.
  • Livforsakringsbolaget Skandia fully exited BUCKEYE TECHNOLOGY INC in Q3 2013, selling an estimated $815K.
  • Livforsakringsbolaget Skandia's ten largest holdings make up 24% of its $145M portfolio in Q3 2013.
  • Livforsakringsbolaget Skandia opened 12 new positions and closed 19 in Q3 2013.
  • Livforsakringsbolaget Skandia's portfolio value rose 4.2% quarter-over-quarter to $145M.

Based on Livforsakringsbolaget Skandia's 13F filing for Q3 2013, filed 16 Oct 2013.